Author

Chu Xin Ng

View on Semantic Scholar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

Overall, CRISPR/Cas9 represents a promising yet evolving platform in oncology, with its future clinical success dependent on achieving a balance between precision, safety, scalability, and long-term therapeutic durability.

Chu Xin Ng, Sakina Mustafa, X. Y. Yap et al. · Frontiers in Oncology · 0 citations